• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Transanal Total Mesorectal Excision (taTME) for Rectal Lesions: Clinical and Oncological Outcomes of 130 Consecutive Patients at a Single Center

Transanal Total Mesorectal Excision (taTME) for Rectal Lesions: Clinical and Oncological Outcomes of 130 Consecutive Patients at a Single Center

Arman Erkan, MD, Abdul Waheed, MD, Matthew R Albert, MD, FACS, FASCRS, Justin Kelly, MD, FRCS, John R Monson, MD, FACS, FRCS, FASCRS. Surgical Health Outcomes Consortium, Florida Hospital Medical Center

Introduction: Transanal total mesorectal excision (taTME) is a novel emerging technique to facilitate pelvic dissection in low rectal lesions. This technique is still in its evolutionary phase and in the United States (US), the published data for taTME is limited to a small number of cohorts. The current study describes the largest clinical and oncological outcomes of taTME in patients with benign and malignant rectal lesions from a single institution in the US.

Methods: Data of 130 patients with benign and malignant rectal lesions from 2012 to 2017 at Florida Hospital was extracted. The primary outcome observed was the quality of TME specimen. Data was analyzed for age, gender, stage, Basal Metabolic Index (BMI), treatment, readmission, complications, type of neoadjuvant therapy and intactness of the mesorectum.

Objective:

Primary endpoint: Quality of TME specimen

Secondary endpoints: Short-term patient and procedure-related adverse events.

Results: A total of 130 consecutively registered cases were analyzed comprising of 80.8% cases with rectal cancer and 19.2% with a benign pathology. 62.3% patients were male, and 37.7% were female with a mean age of 56.4 years, height 172.1 cm, weight 78.8 Kg, and BMI 26.5 Kg/m2. Almost 77.7% of patients had a previous smoking history with comorbidities including active inflammatory bowel disease (20.8%), ischemic heart disease (14.6), diabetes mellitus (12.3%), and steroid use (11.5%). The mean distance of the lesion from the anal verge was 5.0 cm (range 1-10 cm), and had a well-differentiated histology pattern (74%). Preoperative circumferential margin (CRM) involvement on MRI was 30.5% and mean CRM measured was 8.8 mm. The mean number of lymph nodes harvested were 19.1. Additionally, 94.1% of patients had lower anterior resectoin (LAR), and 5.9 % received abdominoperineal resection (APR).  TME grade was complete in 79.5% of patients, nearly complete in 18.1% and incomplete in 2.4% of patients. At final pathology, the distal resection margins were negative in 99% of cases. No immediate 30-day mortality was observed. Furthermore, 13.8% patients had postoperative ileus, 9.4 % had anastomotic leak, 8.2 % developed pelvic abscess, and 3.1% suffered from urinary retention. 

Conclusion: taTME is a technically feasible method in the management of benign and malignant rectal lesions. It provides an ontologically safe and effective approach for the mesorectal dissection with excellent specimen quality. Structured training and more adequately powered studies are required to assess this technique further and establish its widespread utilization.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 91261

Program Number: ETP851

Presentation Session: Emerging Technology iPoster Session (Non CME)

Presentation Type: Poster

30

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals